DEREK SUSALLA: Open Payments
NPI 1508392796 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115,692 in 205 payments from 6 companies in 2025. Trend: 2023 $32,259 · 2024 $73,413 · 2025 $115,692
Honoraria: $81,922Speaker / faculty: $22,500Travel & lodging: $8,520Food & beverage: $2,576Consulting: $174
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 114 | $73,657 |
| ABBVIE INC. | 46 | $23,353 |
| Supernus Pharmaceuticals, Inc. | 41 | $18,404 |
| Otsuka America Pharmaceutical, Inc. | 1 | $174 |
| Tris Pharma Inc | 1 | $63 |
| Lundbeck LLC | 2 | $41 |
Products named: Auvelity, VRAYLAR, Qelbree, Dyanavel XR, REXULTI.
Industry payments across MI — which companies pay providers there.
